Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 9, 2022
Reporting Period: Fiscal third quarter ended September 30, 2022
This filing serves to announce the Company's results of operations and financial condition for the specified quarter via a press release incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. The filing explicitly states that the detailed financial results (including revenue, profit, cash flow, margins, debt, and liquidity) are contained within the attached press release (Exhibit 99.1), which is furnished but not deemed "filed" for purposes of Section 18 of the Exchange Act. Therefore, no specific financial metrics can be extracted from this document alone.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only references the announcement of the third-quarter results.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. These details are presumed to be within the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for actual revenue, net income, and cash flow figures for the quarter ended September 30, 2022.
- Verify year-over-year and quarter-over-quarter performance trends in the full press release.
- Check for any updated financial guidance or operational outlook provided in the press release.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the referenced exhibit.